i360 Medical signs diagnostic deal with US and Asian firms
Published 24/12/2015 | 02:30
I360 Medical, the Irish healthcare and medical device company, has signed a deal with the US-based Feinstein Institute for Medical Research and Singapore's Diagnostics Development Hub.
The deal has been agreed to target the development of medical device and diagnostic technologies with an initial focus on surgical procedures, intra-operative diagnostics and diabetic management.
The chief executive of i360 Medical, Derek Young, said the deal will help benefit patients.
"Both of our partners are recognised as global leaders in their areas are we are excited to combine our networks with the goal of developing and commercialising breakthrough technologies for the healthcare of tomorrow," Mr Young said.
The firm's chief executive also believes that the deal will help add to Ireland's growing medical start-up scene.
"This will benefit Ireland by bringing more 'medtech' startups here and by leveraging the combined international network of the three bodies to launch these startups commercially into the international healthcare markets," Mr Young added.